Канал: Pharmacology Classroom

24 October 2022

24 October 2022

OSPE Demonstration

OSPE Demonstration

OSPE: USE OF AN INHALER

OSPE: USE OF AN INHALER

OSPE: dry syrup preparation

OSPE: dry syrup preparation

FIBRINOLYTIC DRUGS

FIBRINOLYTIC DRUGS

ANTIPLATELET DRUGS

ANTIPLATELET DRUGS

ANTICOAGULANTS

ANTICOAGULANTS

ANTIARRHYTHMIC DRUGS

ANTIARRHYTHMIC DRUGS

DRUGS USED IN HEART FAILURE: PART 2

DRUGS USED IN HEART FAILURE: PART 2

DRUGS USED IN HEART FAILURE: PART-1

DRUGS USED IN HEART FAILURE: PART-1

Lipid lowering drugs

Lipid lowering drugs

DIURETICS

DIURETICS

ANTI HYPERTENSIVE DRUGS: ACEI & ARBS

ANTI HYPERTENSIVE DRUGS: ACEI & ARBS

Management of MI

Management of MI

Anti Anginal Drugs

Anti Anginal Drugs

Anti-adrenergic drugs: Part 2 (beta blockers)

Anti-adrenergic drugs: Part 2 (beta blockers)

Anti adrenergic drugs part 1: alpha blockers

Anti adrenergic drugs part 1: alpha blockers

PHARMACOLOGY OF GLAUCOMA

PHARMACOLOGY OF GLAUCOMA

PHARMACOLOGY OF SHOCK

PHARMACOLOGY OF SHOCK

Adrenergic pharmacology part 2: adrenergic agonists

Adrenergic pharmacology part 2: adrenergic agonists

Adrenergic pharmacology: part 1

Adrenergic pharmacology: part 1

ANS pharma: part 7 (anticholinergic drugs B)

ANS pharma: part 7 (anticholinergic drugs B)

ANS pharma: part 6 (anticholinergic drugs A)

ANS pharma: part 6 (anticholinergic drugs A)

ANS pharma: part 5 (OPC poisoning)

ANS pharma: part 5 (OPC poisoning)

ANS pharma: part 4 (anticholinesterases)

ANS pharma: part 4 (anticholinesterases)

ANS pharma: part 3 (cholinergic agonists)

ANS pharma: part 3 (cholinergic agonists)

ANS pharma: Part-2 (cholinergic system)

ANS pharma: Part-2 (cholinergic system)

Autonomic Pharmacology: part 1 (neurotransmitters)

Autonomic Pharmacology: part 1 (neurotransmitters)

How to study effectively in medical college: Part 2

How to study effectively in medical college: Part 2

How to study effectively in medical college: Part 1

How to study effectively in medical college: Part 1

Drug interactions: part 3 (Pharmacodynamic drug interactions)

Drug interactions: part 3 (Pharmacodynamic drug interactions)

Drug interactions: part 2 (Pharmacokinetic drug interactions)

Drug interactions: part 2 (Pharmacokinetic drug interactions)

Drug interactions: part 1 (synergism & antagonism)

Drug interactions: part 1 (synergism & antagonism)

Adverse drug reactions: part 2 (Type C,D,E reactions, Anaphylactic shock & Pharmacovigilance)

Adverse drug reactions: part 2 (Type C,D,E reactions, Anaphylactic shock & Pharmacovigilance)

Adverse drug reaction: part 1 (Type-A & Type - B)

Adverse drug reaction: part 1 (Type-A & Type - B)

Pharmacodynamics: part 6 (receptor mechanism & the concept of 2nd messengers)

Pharmacodynamics: part 6 (receptor mechanism & the concept of 2nd messengers)

Pharmacodynamics: part 5 (Up & down regulation)

Pharmacodynamics: part 5 (Up & down regulation)

Pharmacodynamics: part 4 (agonists, antagonists types, spare receptor)

Pharmacodynamics: part 4 (agonists, antagonists types, spare receptor)

Pharmacodynamics: part 3 (Receptors and drug-receptor interaction, agonists)

Pharmacodynamics: part 3 (Receptors and drug-receptor interaction, agonists)

Pharmacodynamics: part 2 (Specific & Nonspecific mechanisms of drug action)

Pharmacodynamics: part 2 (Specific & Nonspecific mechanisms of drug action)

Introduction to Pharmacodynamics: the specific mechanisms

Introduction to Pharmacodynamics: the specific mechanisms

Clinical pharma: Part 4 (potency, efficacy, ED50, TD50, LD50, TI)

Clinical pharma: Part 4 (potency, efficacy, ED50, TD50, LD50, TI)

Clinical Pharma: Part 3 (steady state conc, loading & maintenance dose, Dose response relationships)

Clinical Pharma: Part 3 (steady state conc, loading & maintenance dose, Dose response relationships)

Clinical Pharma: Part 2 (order of kinetics, Vd, clearance & half life)

Clinical Pharma: Part 2 (order of kinetics, Vd, clearance & half life)

Clinical pharma: Part 1 (order of kinetics)

Clinical pharma: Part 1 (order of kinetics)